Jeffrey Scott Sherman insider trades: Neogenomics (NEO) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Jeffrey reports to the SEC
Open-market buys and sales
16 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Aug 6, 2025 | NEO | ↑ Buy | 20,000 | $5.62 | $112K | Direct | Aug 6, 2025 (0d) |
| May 2, 2025 | NEO | ↑ Buy | 20,000 | $7.51 | $150K | Direct | May 6, 2025 (4d) |
| Aug 26, 2019 | HMSY | ↓ Sell | 55,092 | $37.14 | $2.0M | Direct | Aug 28, 2019 (2d) |
| Aug 23, 2019 | HMSY | ↓ Sell | 51,500 | $38.16 | $2.0M | Direct | Aug 26, 2019 (3d) |
| Aug 21, 2019 | HMSY | ↓ Sell | 35,896 | $38.83 | $1.4M | Direct | Aug 22, 2019 (1d) |
| Aug 9, 2019 | HMSY | ↓ Sell | 86,485 | $38.12 | $3.3M | Direct | Aug 12, 2019 (3d) |
| Aug 7, 2019 | HMSY | ↓ Sell | 34,730 | $37.96 | $1.3M | Direct | Aug 8, 2019 (1d) |
| Mar 1, 2019 | HMSY | ↓ Sell | 4,030 | $34.08 | $137K | Direct | Mar 4, 2019 (3d) |
| Feb 28, 2019 | HMSY | ↓ Sell | 268,426 | $34.55 | $9.3M | Direct | Feb 28, 2019 (0d) |
| Dec 13, 2018 | HMSY | ↓ Sell | 11,502 | $34.75 | $400K | Direct | Dec 17, 2018 (4d) |
| Dec 12, 2018 | HMSY | ↓ Sell | 11,422 | $35.30 | $403K | Direct | Dec 12, 2018 (0d) |
| Dec 4, 2018 | HMSY | ↓ Sell | 4,205 | $35.69 | $150K | Direct | Dec 6, 2018 (2d) |
| Nov 30, 2018 | HMSY | ↓ Sell | 14,681 | $35.69 | $524K | Direct | Nov 30, 2018 (0d) |
| Nov 26, 2018 | HMSY | ↓ Sell | 2,972 | $35.72 | $106K | Direct | Nov 27, 2018 (1d) |
| Nov 21, 2018 | HMSY | ↓ Sell | 8,600 | $35.97 | $309K | Direct | Nov 21, 2018 (0d) |
| Aug 13, 2015 | HMSY | ↑ Buy | 10,760 | $9.30 | $100K | By Family Trust | Aug 14, 2015 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other NEO insiders
Open-market trades in the last 12 months
About Jeffrey Scott Sherman's insider trades
Jeffrey Scott Sherman is Chief Financial Officer at Neogenomics (NEO). Since Aug 13, 2015, Jeffrey has reported 3 open-market purchases worth $363K and 13 sales worth $21.3M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (26 filings), shares withheld for taxes (24 filings), option exercises (17 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every NEO insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.